Go Pro
→ Trump's New Dollar (From Porter & Company) (Ad)tc pixel Free RNA Stock Alerts

Avidity Biosciences (RNA) Stock Chart & Stock Price History

Avidity Biosciences logo
$14.19 0.00 (0.00%)
As of 09/4/2026 04:00 PM Eastern
Compare

Avidity Biosciences Stock Price Performance

The Avidity Biosciences (RNA) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 71.82%, with a year-to-date return of -80.33%. In the past month, the stock has increased 14.99%, reflecting recent market activity.

As of the latest close, Avidity Biosciences traded at $14.19 with a market cap of $242.73 million and volume of 167,785 shares. Five years ago, the stock traded at $21.82, representing a 34.97% decrease over that period. At the time, it had a market cap of $821.96 million and a volume of 868,743 shares.

Receive RNA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Avidity Biosciences and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
5 Day
Performance
+0.92%
1 Month
Performance
+14.99%
3 Month
Performance
+20.25%
Year-To-Date
Performance
-80.33%
1 Year
Performance
-71.82%
5 Year
Performance
-34.97%

RNA Stock Chart for Monday, September, 7, 2026

RNA Chart by TradingView

Avidity Biosciences Stock Price History

Export
DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization
09/04/2026$14.60$14.19
-2.81%		$14.65$14.01167,785 shs$242.79 million
09/03/2026$14.06$14.60
+3.84%		$14.68$13.99164,904 shs$249.75 million
09/02/2026$13.77$14.06
+2.11%		$14.10$13.76111,638 shs$240.57 million
09/01/2026$13.32$13.77
+3.38%		$13.92$13.20178,348 shs$235.61 million
08/31/2026$13.64$13.32
-2.35%		$13.55$13.1097,049 shs$227.85 million
08/28/2026$13.98$13.64
-2.43%		$13.95$13.51108,636 shs$233.33 million
08/27/2026$13.85$13.98
+0.94%		$14.09$13.59120,386 shs$239.20 million
08/26/2026$14.00$13.85
-1.07%		$14.07$13.66179,349 shs$236.97 million
08/25/2026$13.62$14.00
+2.79%		$14.05$13.41166,577 shs$239.48 million
08/24/2026$13.20$13.62
+3.18%		$13.64$13.04140,452 shs$233.04 million
08/21/2026$13.48$13.20
-2.08%		$13.59$12.96180,676 shs$225.85 million
08/20/2026$13.71$13.48
-1.68%		$13.88$13.20218,806 shs$230.64 million
08/19/2026$12.84$13.71
+6.78%		$13.72$12.85359,716 shs$234.52 million
08/18/2026$12.96$12.84
-0.93%		$12.96$12.72107,917 shs$219.69 million
08/17/2026$12.84$12.96
+0.93%		$13.35$12.78212,552 shs$221.75 million
08/14/2026$12.33$12.84
+4.14%		$12.97$12.08176,079 shs$219.69 million
08/13/2026$12.17$12.33
+1.31%		$12.46$12.03127,102 shs$210.92 million
08/12/2026$12.27$12.17
-0.81%		$12.35$12.0684,170 shs$208.23 million
08/11/2026$12.24$12.27
+0.25%		$12.44$12.2084,152 shs$209.94 million
08/10/2026$12.34$12.24
-0.81%		$12.44$12.20107,981 shs$209.38 million
08/07/2026$12.11$12.34
+1.90%		$12.49$12.15103,281 shs$211.09 million
08/06/2026$11.74$12.11
+3.15%		$12.31$11.88193,101 shs$207.15 million
Related Companies

This page (NASDAQ:RNA) was last updated on 9/4/2026 by MarketBeat.com Staff.
From Our Partners
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
Small Colorado Company (Backed by Sam Altman) Could Save U.S. Power Grid
A small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...
Altimetry | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
The $15 Gold Fund That Pays Up to $1,152/Month
Gold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...
Investors Alley | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
My top 3 AI picks for the next decade
Alexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...
The Oxford Club | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel